HPLC determination of bendrofluazide in capsules

A.R. Barnes; S. Nash

doi:10.1016/0378-5173(93)90028-E

HPLC determination of bendrofluazide in capsules

A.R. Barnes, S. Nash

Aston Pharmacy School

Research output: Contribution to journal › Article › peer-review

Abstract

A high-performance liquid Chromatographie method for the determination of bendrofluazide in extemporaneously prepared 1.25 mg capsules is described. This employs a hexyl reversed-phase column, maintained at ambient temperature. The method is stability-indicating and the mean within-day recovery of bendrofluazide from the capsules was 100.2% (±3.8%, 95% confidence limits).

Original language	English
Pages (from-to)	231-234
Number of pages	4
Journal	International Journal of Pharmaceutics
Volume	94
Issue number	1-3
DOIs	https://doi.org/10.1016/0378-5173(93)90028-E
Publication status	Published - 21 Jun 1993

Keywords

assay
bendrofluazide
capsules
HPLC
tablets

Access to Document

10.1016/0378-5173(93)90028-E

Cite this

@article{6da035760d1942e6ad5b639672beff40,

title = "HPLC determination of bendrofluazide in capsules",

abstract = "A high-performance liquid Chromatographie method for the determination of bendrofluazide in extemporaneously prepared 1.25 mg capsules is described. This employs a hexyl reversed-phase column, maintained at ambient temperature. The method is stability-indicating and the mean within-day recovery of bendrofluazide from the capsules was 100.2% (±3.8%, 95% confidence limits).",

keywords = "assay, bendrofluazide, capsules, HPLC, tablets",

author = "A.R. Barnes and S. Nash",

year = "1993",

month = jun,

day = "21",

doi = "10.1016/0378-5173(93)90028-E",

language = "English",

volume = "94",

pages = "231--234",

journal = "International Journal of Pharmaceutics",

issn = "0378-5173",

publisher = "Elsevier",

number = "1-3",

}

TY - JOUR

T1 - HPLC determination of bendrofluazide in capsules

AU - Barnes, A.R.

AU - Nash, S.

PY - 1993/6/21

Y1 - 1993/6/21

N2 - A high-performance liquid Chromatographie method for the determination of bendrofluazide in extemporaneously prepared 1.25 mg capsules is described. This employs a hexyl reversed-phase column, maintained at ambient temperature. The method is stability-indicating and the mean within-day recovery of bendrofluazide from the capsules was 100.2% (±3.8%, 95% confidence limits).

AB - A high-performance liquid Chromatographie method for the determination of bendrofluazide in extemporaneously prepared 1.25 mg capsules is described. This employs a hexyl reversed-phase column, maintained at ambient temperature. The method is stability-indicating and the mean within-day recovery of bendrofluazide from the capsules was 100.2% (±3.8%, 95% confidence limits).

KW - assay

KW - bendrofluazide

KW - capsules

KW - HPLC

KW - tablets

UR - http://www.scopus.com/inward/record.url?scp=0027164448&partnerID=8YFLogxK

U2 - 10.1016/0378-5173(93)90028-E

DO - 10.1016/0378-5173(93)90028-E

M3 - Article

AN - SCOPUS:0027164448

SN - 0378-5173

VL - 94

SP - 231

EP - 234

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

IS - 1-3

ER -

HPLC determination of bendrofluazide in capsules

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this